Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

474

Participants

Timeline

Start Date

February 22, 2019

Primary Completion Date

October 25, 2025

Study Completion Date

October 25, 2025

Conditions
Mycobacterium Avium ComplexNontuberculous Mycobacterium Infection
Interventions
DRUG

Azithromycin

Azithromycin 500 MG Oral Tablet \[ZITHROMAX\]

DRUG

Ethambutol

Ethambutol 25 mg/kg \[MYAMBUTOL\]

DRUG

Rifampin

Rifampin 600 MG \[RIFADIN\]

Trial Locations (26)

10016

New York University, New York

10032

Columbia University Medical Center, New York

11030

Northwell Health, Manhasset

19140

Temple University, Philadelphia

21224

Johns Hopkins University, Baltimore

27599

University of North Carolina, Chapel Hill

29425

Medical University of South Carolina, Charleston

30322

Emory University, Atlanta

33136

University of Miami, Miami

33612

Tampa VA Medical Center, Tampa

52242

University of Iowa, Iowa City

53705

University of Wisconsin School of Medicine and Public Health, Madison

55905

Mayo Clinic, Rochester

66160

University of Kansas, Kansas City

70112

Louisina State University, New Orleans

75708

University of Texas Health Science Center, Tyler

80206

National Jewish Health, Denver

92103

University of California, San Diego, San Diego

92354

Loma Linda University Medical Center, Loma Linda

94110

University of California, San Francisco, San Francisco

94305

Stanford University, Stanford

96817

Kaiser Permanente Hawaii, Honolulu

97239

Oregon Health & Science University, Portland

98104

University of Washington, Seattle

98664

Vancouver Clinic, Vancouver

M5T2S8

University Health Network, Toronto

Sponsors
All Listed Sponsors
collaborator

Patient-Centered Outcomes Research Institute

OTHER

collaborator

National Jewish Health

OTHER

collaborator

The University of Texas Health Science Center at Tyler

OTHER

collaborator

University Health Network, Toronto

OTHER

collaborator

New York University

OTHER

collaborator

Medical University of South Carolina

OTHER

collaborator

Mayo Clinic

OTHER

collaborator

Louisiana State University Health Sciences Center in New Orleans

OTHER

collaborator

University of California, San Diego

OTHER

collaborator

Stanford University

OTHER

collaborator

University of Kansas

OTHER

collaborator

Vancouver Clinic

UNKNOWN

collaborator

University of California, San Francisco

OTHER

collaborator

University of Washington

OTHER

collaborator

Johns Hopkins University

OTHER

collaborator

University of Miami

OTHER

collaborator

Emory University

OTHER

collaborator

University of Iowa

OTHER

collaborator

University of North Carolina

OTHER

collaborator

Temple University

OTHER

collaborator

Loma Linda University

OTHER

collaborator

Columbia University

OTHER

collaborator

University of Wisconsin, Madison

OTHER

collaborator

Northwell Health

OTHER

collaborator

Kaiser Permanente

OTHER

collaborator

James A. Haley Veterans Administration Hospital

FED

lead

Kevin Winthrop

OTHER

NCT03672630 - Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease | Biotech Hunter | Biotech Hunter